Trials / Terminated
TerminatedNCT03222102
Ventral Hernia Prevention After Liver Transplantation
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Medical University of Graz · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to evaluate if the risk of developing ventral hernia after liver transplantation can be reduced through the prophylactic implantation of a synthetic, fully resorbable mesh "Phasix" in the course of liver transplantation. Patients will be randomized in a 1:1 ratio to receive either Phasix mesh or standard surgery without the use of Phasix. Ultra-sound examinations of the wound area will be performed 14 days, 3, 6 and 12 months after liver transplantation. Furthermore, presence of infections, seroma, pain and other problems in the wound area will be assessed.
Detailed description
Ventral hernia is a frequently occurring complication following liver transplantation, with a reported risk in the literature ranging from 5% to 25%. This study aims to evaluate if the risk of developing ventral hernia after liver transplantation can be reduced through the prophylactic implantation of a synthetic mesh "Phasix" in the course of liver transplantation. PHASIX™ Mesh is a fully resorbable mesh implant prepared from poly-4-hydroxybutyrate (P4HB). Absorption of the mesh material occurs within 12 to 18 months. Patients will be randomized in a 1:1 ratio to receive either Phasix mesh in the course of liver transplantation or standard surgery without the use of Phasix. Ultra-sound examinations of the wound area will be performed 14 days, 3, 6 and 12 months after liver transplantation. Furthermore, presence of infections, seroma, pain and other problems in the wound area will be assessed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Phasix mesh | After the closure of the Abdomen, Phasix mesh will be placed and affixed on the exposed fascia. |
Timeline
- Start date
- 2017-11-30
- Primary completion
- 2023-11-04
- Completion
- 2023-11-04
- First posted
- 2017-07-19
- Last updated
- 2025-01-27
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT03222102. Inclusion in this directory is not an endorsement.